PEGylated Liposomal Encapsulation Improves the Antitumor Efficacy of Combretastatin A4 in Murine 4T1 Triple-Negative Breast Cancer Model

2021 ◽  
pp. 121396
Author(s):  
Farshad Mirzavi ◽  
Mehdi Barati ◽  
Roghayyeh Vakili-Ghartavol ◽  
Mostafa Karimi Roshan ◽  
Mohammad Mashreghi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Antitumor Efficacy ◽  
Cancer Model ◽  
Breast Cancer Model ◽  
Combretastatin A4

scholarly journals Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness

Neoplasia ◽  
2014 ◽  
Vol 16 (1) ◽  
pp. 43-W19 ◽  
Author(s):  
Pradip De ◽  
Yuling Sun ◽  
Jennifer H. Carlson ◽  
Lori S. Friedman ◽  
Brian R. Leyland-Jones ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Parp Inhibitor ◽  
Mtor Pathway ◽  
Antitumor Efficacy ◽  
Cancer Model ◽  
Breast Cancer Model

scholarly journals Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems

Oncotarget ◽  
2017 ◽  
Vol 8 (46) ◽  
pp. 80804-80819 ◽  
Author(s):  
Teddy S. Nagaria ◽  
Changnian Shi ◽  
Charles Leduc ◽  
Victoria Hoskin ◽  
Soma Sikdar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Model Systems ◽  
Cancer Model ◽  
Breast Cancer Model
Sign in / Sign up

Export Citation Format

Share Document